COMP <GO>
INNV vs TDOC // 10Y YIELD & FRED MACRO BETA
InnovAge Holding Corp. (NASDAQ) VS. Teladoc Health Inc. (NYSE) • 15-METRIC TALLY: INNV 5
— TDOC 4
■ METRIC PARITY
LAST: $8.92 (-2.94%) • MKT CAP: $1.25B
macro-sensitivity
—
LAST: $8.63 (+1.41%) • MKT CAP: $1.55B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INNV VS. TDOC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INNV | TDOC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | -17.00% | +6.80 | INNV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 18.00% | -15.89 | TDOC | /fcf-yield <GO> |
| Operating Margin | -3.50% | -10.40% | +6.90 | INNV | /operating-margins <GO> |
| Net Profit Margin | -3.60% | -7.90% | +4.30 | INNV | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | -1.50% | +13.30 | INNV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.47 | 0.45 | +4.02 | INNV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | TDOC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 74.1 | -28.20 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 32.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.25B | $1.55B | -$297.3M | TDOC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INNV REV | TDOC REV | INNV GROSS % | TDOC GROSS % | INNV FCF | TDOC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $853.7M | $2.53B | 18.0% | — | $26.6M | $285.5M |
| FY 2024 | $763.9M | $2.57B | 17.3% | — | -$44.8M | $282.9M |
| FY 2023 | $688.1M | $2.60B | — | — | $20.2M | $232.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INNV // BETA —
TDOC // BETA 1.08